Filing Details

Accession Number:
0001127602-12-033742
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-12 16:58:16
Reporting Period:
2012-12-10
Filing Date:
2012-12-12
Accepted Time:
2012-12-12 16:58:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1156039 Wellpoint Inc WLP Hospital & Medical Service Plans (6324) 352145715
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1321392 S Wayne Deveydt 120 Monument Circle
Indianapolis IN 46204
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-12-10 12,684 $58.21 105,138 No 4 F Direct
Common Stock Acquisiton 2012-12-11 38,453 $30.10 143,591 No 4 M Direct
Common Stock Disposition 2012-12-11 36,373 $58.05 107,218 No 4 S Direct
Common Stock Disposition 2012-12-11 60,419 $58.37 46,799 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2012-12-11 38,453 $0.00 38,453 $30.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-03-02 No 4 M Direct
Footnotes
  1. Payment of tax liability by withholding stock incident to the vesting of previously granted restricted stock.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2012.
  3. This transaction was executed in multiple trades at prices ranging from $57.28 to $58.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $58.28 to $58.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. Exercised options vested as follows: 19,226 on 9/2/2011 and 19,227 on 3/2/2012.